Date Range
toReport Types
Condition
See all (12)
Region of the Body
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
THC/CBD oromucosal spray is not better than placebo for diabetic neuropathy over 12 weeks
Diabetes Care. 2010 ;33(1):128-130. http://dx.doi.org/10.2337/dc09-1029
Titrated THC and CBD does not significantly improve spasticity compared to placebo over 4 weeks
J Neurol. 2015 Nov;262(11):2520-7
Nabiximol effective and safe in managing spasticity in patients with refractory MS
Neurol Res. 2010 Jun;32(5):451-9. doi: 10.1179/016164109X12590518685660
Cannabis medicinal extract effective in improving some neurogenic symptoms - a pilot study
Clin Rehabil. 2003 Feb;17(1):21-9.
Titrated THC:CBD Improves Pain and Spasticity Compared to Placebo Over 12 Weeks for Resistant MS
Int J Neurosci. 2018 Sep 13:1-10.
Cannabis-based medicinal extracts effective in managing spasticity, but not other symptoms of MS
Mult Scler. 2004 Aug;10(4):434-41.
Sativex effective in alleviating pain and allodynia from neuropathy after 5-week follow up
Pain. 2007 Dec 15;133(1-3):210-20
Oral THC/CBD spray provides neuropathic pain control in MS patients, with mild/moderate side effects
Clin Ther. 2007 Sep;29(9):2068-79
Comparing THC, CBD, 1:1 mixture of THC:CBD, and placebo in management of patients with chronic pain
Anaesthesia. 2004 May;59(5):440-52
Synthetic CBD for Psoriatic Arthritis and Hand Osteoarthritis
Pain. 2022 01-Jun;():. 10.1097/j.pain.0000000000002466
Oral Cannabidiol Does Not Reduce Acute Non-traumatic Low Back Pain
Med J Aust. 2021 01-May;():. 10.5694/mja2.51014
CBD 600mg Normalizes Neuroendocrine and Anxiety Responses to Stress in Patients at Risk of Psychosis
Psychopharmacology. 2020 ;():. 10.1007/s00213-019-05442-6
Efficacy of a cannabis-based oromucosal spray in managing peripheral neuropathic pain
Eur J Pain. 2014 Aug;18(7):999-1012. doi: 10.1002/j.1532-2149.2013.00445.x
Buccally Absorbed Cannabidiol for Pain Control After Arthroscopic Rotator Cuff Repair
Am J Sports Med. 2022 01-Jul;():. 10.1177/03635465221109573
Cannabis oromucosal spray slightly decreases neuropathic pain from brachial plexus injury
Pain. 2004;(3):299-306.
Cannabis oralmucosal spray does not significantly improve neuropathic pain from multiple sclerosis
J Neurol. 2013 Apr;260(4):984-97. doi: 10.1007/s00415-012-6739-4
Efficacy of a cannabis-based oromucosal spray in managing pain of rheumatoid arthritis
Rheumatology (Oxford, England). 2006;(1):Feb-50.
Oromucosal route of delivering cannabis based medicine safe and effective in pain reduction
Neurology. 2005 Sep 27;65(6):812-9
Nabiximols improves multiple sclerosis spasticity compared to placebo over 12 weeks
Eur J Neurol. 2011 Sep;18(9):1122-31. doi: 10.1111/j.1468-1331.2010.03328.x